⌘K

Login Start Free

Home/Filings/4/0001209191-22-019684

4//SEC Filing

Nash Huw M. 4

Accession 0001209191-22-019684

CIK 0001623526other

View on SEC.gov Company Profile

Filed

Mar 16, 8:00 PM ET

Accepted

Mar 17, 5:13 PM ET

Size

5.5 KB

Accession

0001209191-22-019684

Insider Transaction Report

Form 4

Period: 2022-03-15

Stoke Therapeutics, Inc.STOK

COO & CBO

Transactions

Award
Employee Stock Option (Right to Buy)
2022-03-15+107,400→ 107,400 total
Exercise: $20.34Exp: 2032-03-14→ Common Stock (107,400 underlying)

Footnotes (1)

[F1]The option vests as to 1/48th of the total shares on April 15, 2022 and then 1/48th of the total shares vest monthly thereafter, subject to reporting person's continued service to the issuer through each vesting date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Stoke Therapeutics, Inc.

CIK 0001623526

Entity typeother

Related Parties

1

filerCIK 0001780085

Filing Metadata

Form type: 4
Filed: Mar 16, 8:00 PM ET
Accepted: Mar 17, 5:13 PM ET
Size: 5.5 KB

View on SEC.gov